Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.

PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

Pharmaceutical major recorded a revenue jump to $14.65 billion, exceeding the market expectations. The company also raised ...

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...

Shares in the data-software company were up 7.8% Tuesday after it posted higher quarterly results and [boosted its annual ...

Second Quarter 2025 Results Key Financial Results Revenue: US$14.7b (up 10% from 2Q 2024).

XAU/USD consolidates above the 50-day MA, as softer U.S. data boosts rate cut odds. Gold price future hinges on inflation and ...

Trump has said that tariffs on pharmaceutical imports could reach 250%, the steepest rate he has proposed for the sector. Trump, who in July threatened 200% duties, wants to motivate drug companies to ...

Hims & Hers Health posted an increase in profit and revenue for the second quarter on growth in subscribers using personalized treatment plans. The telehealth-consultation platform on Monday posted a ...

NASDAQ tested new highs, supported by the strong performance of Apple stock. Shopify, which gained 21.2%, was the biggest ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

New data highlights an unprecedented crisis in National Health Service patient waiting lists and sheds light on how the ...